FREAMINE III 3% W/ ELECTROLYTES(AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE)

药品名称	FREAMINE III 3% W/ ELECTROLYTES
申请号	016822	产品号	003
活性成分	AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE	市场状态	处方药
剂型或给药途径	INJECTABLE;INJECTION	规格	3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML
治疗等效代码		参比药物	否
批准日期	Approved Prior to Jan 1, 1982	申请机构	B BRAUN MEDICAL INC
化学类型	New combination	审评分类	Priority review drug

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

与本品相关的市场独占权保护信息
独占权代码	失效日期
无
历史市场独占权保护信息
无

与药品注册相关的信息
申请号	修订号	审批结论	公开文档类型	文档创建时间	获取文档
016822	065	AP	Label	2004/06/01	下载
016822	065	AP	Letter	2004/06/01	下载

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
016822	081	AP	2013/11/08	Manufacturing Change or Addition
016822	077	AP	2013/01/09	Manufacturing Change or Addition
016822	075	AP	2013/03/15	Manufacturing Change or Addition
016822	074	AP	2013/03/19	Manufacturing Change or Addition
016822	072	AP	2014/03/12	Manufacturing Change or Addition
016822	065	AP	2004/05/27	Control Supplement
016822	064	AP	2000/06/20	Control Supplement
016822	063	AP	2000/04/12	Control Supplement
016822	062	AP	1999/05/04	Control Supplement
016822	061	AP	1996/06/14	Control Supplement
016822	060	AP	1995/09/13	Control Supplement
016822	059	AP	1994/10/28	Manufacturing Change or Addition
016822	058	AP	1993/06/08	Control Supplement
016822	057	AP	1992/09/28	Manufacturing Change or Addition
016822	056	AP	1991/12/11	Manufacturing Change or Addition
016822	055	AP	1990/04/11	Control Supplement
016822	052	AP	1988/01/13	Labeling Revision
016822	051	AP	1987/12/28	Labeling Revision
016822	050	AP	1987/07/09	Labeling Revision
016822	049	AP	1987/07/09	Labeling Revision
016822	048	AP	1986/10/08	Labeling Revision
016822	047	AP	1985/10/21	Labeling Revision
016822	046	AP	1985/10/21	Labeling Revision
016822	045	AP	1985/06/14	Control Supplement
016822	044	AP	1988/07/01	Labeling Revision
016822	043	AP	1988/07/01	Control Supplement
016822	042	AP	1984/09/08	Labeling Revision
016822	041	AP	1988/04/11	Labeling Revision
016822	040	AP	1988/04/11	Package Change
016822	039	AP	1985/10/15	Labeling Revision
016822	038	AP	1985/10/15	Control Supplement
016822	037	AP	1985/07/23	Labeling Revision
016822	036	AP	1985/07/23	Control Supplement
016822	035	AP	1982/06/29	Formulation Revision
016822	034	AP	1982/08/26	Control Supplement
016822	033	AP	1983/05/17	Labeling Revision
016822	032	AP	1983/05/17	Control Supplement
016822	031	AP	1982/05/03	Control Supplement
016822	030	AP	1983/04/25	Practioner Draft Labeling
016822	029	AP	1982/06/17	Control Supplement
016822	028	AP	1981/05/04	Control Supplement
016822	027	AP	1981/04/10	Control Supplement
016822	026	AP	1981/06/20	Labeling Revision
016822	025	AP	1981/06/20	Control Supplement
016822	024	AP	1980/11/07	Control Supplement
016822	023	AP	1980/12/09	Control Supplement
016822	022	AP	1980/06/25	Expiration Date Change
016822	021	AP	1980/08/07	Labeling Revision
016822	020	AP	1980/08/07	Control Supplement
016822	019	AP	1980/08/20	Control Supplement
016822	018	AP	1980/06/06	Control Supplement
016822	017	AP	1980/04/20	Control Supplement
016822	016	AP	1980/04/17	Labeling Revision
016822	015	AP	1980/04/17	Control Supplement
016822	013	AP	1978/08/18	Labeling Revision
016822	012	AP	1978/10/02	Labeling Revision
016822	011	AP	1978/10/02	Control Supplement
016822	010	AP	1977/07/19	Control Supplement
016822	009	AP	1977/09/01	Control Supplement
016822	007	AP	1977/05/26	General Efficacy (MarkIV)
016822	006	AP	1977/05/06	Labeling Revision
016822	005	AP	1975/01/23	Control Supplement
016822	000	AP	1971/09/24	Approval

返回检索页面